Drug Shortage Report for TARO-MELPHALAN
Report ID | 173733 |
Drug Identification Number | 02480026 |
Brand name | TARO-MELPHALAN |
Common or Proper name | MELPHALAN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BUFFER SOLUTION MELPHALAN |
Strength(s) | 10ML 50MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRA-ARTERIAL |
Packaging size | 50MG |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-01 |
Estimated end date | 2023-06-30 |
Actual end date | 2023-06-30 |
Shortage status | Resolved |
Updated date | 2023-07-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v24 | 2023-07-18 | French | Compare |
v23 | 2023-07-18 | English | Compare |
v22 | 2023-06-09 | French | Compare |
v21 | 2023-06-09 | English | Compare |
v20 | 2023-04-10 | French | Compare |
v19 | 2023-04-10 | English | Compare |
v18 | 2023-03-24 | French | Compare |
v17 | 2023-03-24 | English | Compare |
v16 | 2023-03-10 | French | Compare |
v15 | 2023-03-10 | English | Compare |
v14 | 2023-02-01 | French | Compare |
v13 | 2023-02-01 | English | Compare |
v12 | 2023-01-19 | French | Compare |
v11 | 2023-01-19 | English | Compare |
v10 | 2023-01-10 | French | Compare |
v9 | 2023-01-10 | English | Compare |
v8 | 2022-12-12 | French | Compare |
v7 | 2022-12-12 | English | Compare |
v6 | 2022-11-24 | French | Compare |
v5 | 2022-11-24 | English | Compare |